Shuozhou Huang

Title: Innovations of Shuozhou Huang in Biomedical Technology

Introduction

Shuozhou Huang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of biomedical technology, particularly in the development of chimeric antigen receptors. His work focuses on innovative solutions for targeting tumor cells, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Shuozhou Huang holds a patent for a chimeric antigen receptor and its applications. This chimeric antigen receptor is designed to identify various components of the malarial protein VAR2CSA. It can bind to placental-like chondroitin sulfate A (pl-CSA) on the surface of tumor cells, enabling targeted therapy for different types of tumors. His patent represents a significant advancement in the field of cancer treatment.

Career Highlights

Throughout his career, Shuozhou Huang has worked with prominent companies in the biomedical sector. He has been associated with Cas Lamvac Biomedical Technology Co., Ltd. and Cas Lamvac (Guangzhou) Biomedical Technology Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative biomedical solutions.

Collaborations

Shuozhou Huang has collaborated with notable professionals in his field, including Xiaoping Chen and Ting Jiang. These collaborations have further enhanced his research and development efforts, leading to impactful innovations in biomedical technology.

Conclusion

Shuozhou Huang's contributions to the field of biomedical technology, particularly through his patent on chimeric antigen receptors, highlight his role as an influential inventor. His work continues to pave the way for advancements in targeted cancer therapies.